IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (145)	10/27/1997 9:51:00 PM
From: Mark B. Martell, CCM	Read Replies (2) of 1510

John, No problem. Call IMNR's Investor Relations personnel. She (can't quite remember her name) will forward you a package on what the company is doing in R&D along with financials and company history. As far as I can tell, Remune increases Chemokine production. It doesn't really go after the Aids virus, again, as I understand it. What it does is help support the body's own immunization process so that Protease Inhibitors such as Merck's Crixivan can be more effective over a longer term. Remune truly works in a cocktail fashion. As you may or may not be aware, there has been some recent reports that the virus is adapting to the protease inhibitors, reducing their effectiveness. As Aids wears down the T-cell count, the body succumbs to various other diseases. Remune supposedly helps to alleviate the issue by stimulating a greater autoimmune response. That's the best I can come up with off the top of my head for you. Try to grab those materials from the company to further your research. Good luck....Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next